Sort
8,912 grants matching “sars cov 2”
The impact of T cell selection on vaccine durability
$602,727Laura Su · University Of Pennsylvania · R01 · FY2023 · AI
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression
$602,559Leslee J Shaw · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL
Structural and Functional Characterization of the SARS-CoV-2 Endoribonuclease Nsp15
$602,482Robin Stanley · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Mechanisms of viral proteases in coronavirus replication and pathogenesis
$602,456Susan C. Baker · Loyola University Chicago · R01 · FY2014 · AI
Mechanisms of viral proteases in coronavirus replication and pathogenesis
$602,456Susan C. Baker · Loyola University Chicago · R01 · FY2012 · AI
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
$602,271Lisa Goldman Rosas · Stanford University · R01 · FY2023 · MD
Project 2
$602,235Kristian Graugaard Andersen · Scripps Research Institute, The · U19 · FY2025 · AI
CEIRR: SARS-CoV-2 Research Activities
$602,070Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2024 · AI
COVID Supplement to Terry Beirn CPCRA Clinical Trials Unit
$601,947Virginia Kan · George Washington University · UM1 · FY2020 · AI
Overriding the Immune Evasion Tactics of Coronavirus
$601,563Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AI
Overriding the Immune Evasion Tactics of Coronavirus
$601,563Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AI
Overriding the Immune Evasion Tactics of Coronavirus
$601,563Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AI
Case Clinical Trials Unit: Administrative Supplement NOSI AI-20-031.
$601,237Benigno Rodriguez · Case Western Reserve University · UM1 · FY2020 · AI
hHv1 channels in neutrophils and the innate immune inflammatory response
$600,649Steve A N Goldstein · University Of California-Irvine · R01 · FY2023 · HL
The longitudinal impact of the COVID-19 pandemic and related multi-level mitigation and contextual factors on health and socioeconomic outcomes of individuals and families from a vulnerable population
$600,619Colter M.s. Mitchell · University Of Michigan At Ann Arbor · U01 · FY2023 · HD
Toxicology in the 21st Century Program (Tox21) - Systems Toxicology
$600,500Menghang Xia · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Targeting SARS-CoV-2 PLpro for COVID-19 treatment
$600,292Rui Xiong · University Of Arizona · R01 · FY2023 · AI
Mali International Center for Excellence in Research
$600,116Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Maternal Omics to Maximize Immunity
$600,000Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2024 · AI
The COVID-19 and Cancer Consortium: NCI Administrative Supplement to P30 Cancer Center Support Grant (CCSG)
$600,000Jennifer A Pietenpol · Vanderbilt University Medical Center · P30 · FY2021 · CA
HIV/AIDS Clinical Trials Unit (CTU) COVID-19 Admin Supplement
$600,000Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2020 · AI
San Francisco Bay Clinical Trial Unit: Expanding COVID-19 Testing in Heavily Impacted Communities in San Francisco
$600,000Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2020 · AI
SBIR TOPIC 107 AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GOLDEN HAMSTER
$600,000Hong Qi · Qoolabs, Inc. · N43 · FY2022 · AI
Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease)
$600,000Hong Qi · Qoolabs, Inc. · N43 · FY2023 · AI
Research Project 2 The pregnancy AdaptOME
$600,000Boris Dominik Juelg · Massachusetts Institute Of Technology · U19 · FY2024 · AI